China Micron Ban Not Cause For Further Health Sector Worry?
Multiple Changes Already In Place
Executive Summary
China has taken a new counterstrike against the US in the chips sector, but the risk of potential wider impact on the biopharma sector appears to be limited given other tighter regulations already in place.